000			04160nam a22003495i 4500
001			82537
003			ES-MaUEC
005			20230207040414.0
007			cr nn 008mamaa
008			141202s2015 gw | s |||| 0|eng d
020			_a9783662440063
024	7		_a10.1007/978-3-662-44006-3 _2doi
050		4	_aRC268.3 _b2015 EB
245	1	0	_aCancer Immunology : _bA Translational Medicine Context _cedited by Nima Rezaei.
260			_aBerlin, Heidelberg _bSpringer _c2015
300			_a1 recurso en línea (XLVII, 597 páginas) _b269 ilustraciones, 246 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aIntroduction on cancer immunology and immunotherapy -- Inflammatory and innate immune cells in cancer microenvironment and progression -- Role of innate immunity in cancers and antitumor response -- Role of B cells in anti tumor response -- The role of exhaustion in tumor-induced T cell dysfunction in patients with cancer -- Regulatory T cells and Th17 cells in the immunosuppressive tumor network -- Role of cytokines in tumor immunity and immune tolerance to cancers -- Role of chemokines and chemokine receptors in cancers -- The role of Fas and Fas-ligand in cancers -- MHC class I molecules and cancer progression: Lessons learned from preclinical tumor models -- Role of plasmacytoid dendritic cells in cancer -- Cancer immunoediting: immunosurveillance, immuneequilibrium, and immune escape -- Apoptosis, autophagy and necroptosis in Cancer -- Prognostic value of innate and adaptive immunity in cancers -- Epigenetics and Micro RNAs in cancers -- Immunogenetics of cancers -- Immunodeficiencies and cancers -- Immunosenescence and cancers -- Nutrition, immunity and cancers -- Allergies and cancers -- Cancer immunology of transmissible cancers -- Systems biology and systems immunology of cancer -- Principles of immunological diagnostic tests for cancers -- Flow cytometry in cancer immunotherapy: applications, analysis, quality control and future -- Immunohistochemistry of cancers -- Immunology and immunotherapy of graft versus host disease.Â{u2802}Â{uE000}
520	3		_aCancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. The rapid flow of studies in the field of cancer immunology during the last decade has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it is now well known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the cross-talk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer. This volume is focused on interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. Notably, the principal focus is very much on clinical aspects, the aim being to educate clinicians on the clinical implications of the most recent findings and novel developments in the field. This is to be hoped that this translational book will be comprehensible, cogent and of special value for researchers and clinicians who wish to extend their knowledge on cancer immunology.Â{u2802}Â{uE02F}
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aInmunología _2embne _9138330
650	2	7	_aInmunología _2embne _9138330
700	1		_aRezaei, Nima _eeditor literario _988761 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-662-44006-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b1291177x _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC268.3 C363 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11579456 _z06-04-17
999			_c82537 _d82537 _x1